Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Increases By 173.1%

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 74,992 shares, an increase of 173.1% from the May 14th total of 27,456 shares. Based on an average daily trading volume, of 283,609 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the shares of the company are short sold.

Analyst Upgrades and Downgrades

A number of brokerages have commented on SGIOY. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research report on Wednesday, April 8th. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 0.2%

Shares of SGIOY stock traded down $0.02 during trading hours on Friday, reaching $8.65. The company had a trading volume of 154,681 shares, compared to its average volume of 174,610. Shionogi & Co., Ltd. Unsponsored ADR has a 1-year low of $7.65 and a 1-year high of $12.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.84 and a quick ratio of 5.21. The firm has a market cap of $14.72 billion, a price-to-earnings ratio of 10.81, a P/E/G ratio of 3.32 and a beta of 0.08. The company has a 50 day moving average of $9.75 and a 200 day moving average of $9.88.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. The firm had revenue of $881.71 million during the quarter, compared to analysts’ expectations of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 14.09%. On average, equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.81 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.